Full Fed. Circ. Won't Look At Injunction On MSN's Generic Drug

The full Federal Circuit won't revisit a panel's January order barring MSN Laboratories Pvt. Ltd. from launching a generic version of Novartis' bestseller, the cardiovascular drug Entresto, as part of a...

Already a subscriber? Click here to view full article